X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Insights

Fairfax Behavioral Health to open 34-bed Psychiatric Unit at Valley General Hospital State of Washington Approves Certificate of Need to Expand Psychiatric Care in Region

Yuvraj_pawp by Yuvraj_pawp
5th September 2014
in Insights

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

In a step forward to remedy a state-wide shortage of inpatient psychiatric care beds, Valley General Hospital, an affiliate of EvergreenHealth, today announced that it, together with Fairfax Behavioral Health, received approval from the state to open a 34-bed psychiatric hospital on its campus in Monroe, Washington.

 

The new psychiatric hospital is part of Valley General’s ongoing commitment to provide Snohomish County with access to high-quality care, and is slated to open in 2015.

 

“Across the state, many mental health patients are in crisis with very few options for treatment. Our collaboration with Fairfax Behavioral Health is one positive step forward to ease our state’s overburdened mental health system and help ensure that mental health patients seeking treatment for all forms of illness have access to expert care,” said Eric Jensen, CEO of Valley General Hospital.

 

Under the agreement, Fairfax Behavioral Health will own and operate the psychiatric hospital, providing Snohomish County with improved access to high-quality behavioral health care. The psychiatric hospital will provide services delivered by a multidisciplinary group of qualified professional staff including psychiatrists, nurse practitioners, registered nurses, mental health professionals, psychologists, pharmacists and registered recreational therapists.

 

“This is good news for the residents of east Snohomish County,” said Scott Bond, president and CEO of the Washington State Hospital Association. “Behavioral health services are deeply needed across the state. The establishment of a Fairfax hospital on the Valley General campus will help more people get access to high-quality, specialized care. And just as importantly, they’ll be able to get care close to home.”

 

Inpatient psychiatric hospitalization requires a highly specialized staff, and Fairfax brings a proven track record of effective psychiatric hospital management to the partnership. Fairfax has an 83-year history of service to the Northwest region, and is the largest private provider of inpatient psychiatric services in the state of Washington.

 

“Our county is in great need of additional psychiatric beds, and we saw an opportunity to bring this essential service to the region by partnering with Fairfax. Together, we are working diligently to provide this underserved population with greater access to specialized care, right in our community,” said Jensen.

 

The psychiatric hospital will be located in Valley General Hospital’s F Wing and will treat older adult patients on both a voluntary and involuntary basis. The F Wing previously housed Valley General’s geriatric psychiatric inpatient unit, which closed in 2011.

 

The agreement allows Fairfax to lease a portion of Valley General’s Monroe campus for up to 20 years. Both organizations will remain independent, and Fairfax will be the sole-operator of the psychiatric hospital for the duration of the lease.

About Valley General Hospital
Now affiliated with EvergreenHealth of Kirkland, Washington, Valley General Hospital is an accredited, full-service district hospital located in Monroe, Washington since 1960. The district includes 100,000 people in central and eastern Snohomish County, and provides primary care for community members through the Sky River Medical Group. Valley General’s mission is to serve the changing health care needs of its community. It provides personalized patient care known for quality and excellence with a healing environment through caring relationships.

SOURCE Valley General Hospital

Previous Post

Luye Pharma Acquired 57.98% Stake of Beijing Jialin Pharmaceutical

Next Post

Astellas Receives Notification from FDA of Acceptance of Filing of Isavuconazole NDA for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis

Related Posts

Role of CDMOs In Technology Transfer From Molecule To Market
Insights

Role of CDMOs In Technology Transfer From Molecule To Market

19th June 2025
CDMOs Driving Agile Production Within Intricate Therapies
Insights

CDMOs Driving Agile Production Within Intricate Therapies

19th June 2025
Regulatory Trends in Pharma
Insights

Regulatory Trends in Pharma Manufacturing to Watch in 2025

29th May 2025
Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Insights

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

27th May 2025
Capsules Market
Insights

Empty Capsules Market Growth to Reach $4.2B by 2029

16th April 2025
Next Post

Phase Holographic Imaging Announces Collaboration Agreement with Northeastern University

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In